Skip to main content
OpenTrials

Clinical trial condition

Diabetes Mellitus, Type 2

Explore clinical trials studying Diabetes Mellitus, Type 2. Study availability and eligibility vary by location and protocol.

7,994 public trials 713 recruiting studies
Refine in advanced search Browse all conditions

Diabetes Mellitus, Type 2 trial results

Completed

Comparison of Biphasic Insulin Aspart 70/30 Versus Insulin Glargine in Subjects With Type 2 Diabetes

NCT00097877

Conditions
Diabetes, Diabetes Mellitus, Diabetes Mellitus, Type 2, +4 more
Locations
  • Novo Nordisk Investigational Site Birmingham, Alabama, United States
  • Novo Nordisk Investigational Site Tuscaloosa, Alabama, United States
  • Novo Nordisk Investigational Site Vestavia Hills, Alabama, United States
  • Novo Nordisk Investigational Site Searcy, Arkansas, United States
View all 73 locations
View Trial Details
Completed

Efficacy and Safety of Biphasic Insulin Aspart 30 in Subjects With Type 2 Diabetes

NCT00605111

Conditions
Diabetes, Diabetes Mellitus, Diabetes Mellitus, Type 2, +4 more
Locations
  • Novo Nordisk Investigational Site Blacktown, New South Wales, Australia
  • Novo Nordisk Investigational Site Broadmeadow, New South Wales, Australia
  • Novo Nordisk Investigational Site Fitzroy, Australia
  • Novo Nordisk Investigational Site Garran, Australia
View all 17 locations
View Trial Details
Completed

Comparison of Biphasic Insulin Aspart 70/30 With Anti-Diabetic Drugs in Subjects With Type 2 Diabetes

NCT00097279

Conditions
Diabetes, Diabetes Mellitus, Diabetes Mellitus, Type 2, +4 more
Locations
  • Novo Nordisk Investigational Site Birmingham, Alabama, United States
  • Novo Nordisk Investigational Site Glendale, Arizona, United States
  • Novo Nordisk Investigational Site Phoenix, Arizona, United States
  • Novo Nordisk Investigational Site Searcy, Arkansas, United States
View all 73 locations
View Trial Details
Completed

Biphasic Insulin Aspart 30 in Type 2 Diabetes Failing OAD Therapy

NCT00598793

Conditions
Diabetes, Diabetes Mellitus, Diabetes Mellitus, Type 2, +4 more
Locations
  • Novo Nordisk Investigational Site Concord, California, United States
  • Novo Nordisk Investigational Site Los Angeles, California, United States
  • Novo Nordisk Investigational Site Walnut Creek, California, United States
  • Novo Nordisk Investigational Site Melbourne, Florida, United States
View all 27 locations
View Trial Details
Completed

Pharmacokinetics/Pharmacodynamics of Albiglutide

NCT01357889

Conditions
Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +3 more
Locations
  • GSK Investigational Site Dothan, Alabama, United States
  • GSK Investigational Site Long Beach, California, United States
  • GSK Investigational Site Riverside, California, United States
  • GSK Investigational Site Hallandale, Florida, United States
View all 30 locations
View Trial Details
Completed

Safety and Efficacy Study of Albiglutide in Type 2 Diabetes

NCT00849017

Conditions
Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +3 more
Locations
  • GSK Investigational Site Alabaster, Alabama, United States
  • GSK Investigational Site Birmingham, Alabama, United States
  • GSK Investigational Site Birmingham, Alabama, United States
  • GSK Investigational Site Dothan, Alabama, United States
View all 262 locations
View Trial Details

Related conditions